Resverlogix Receives Ethics Approval for Canadian Sites in Apabetalone COVID-19 Clinical Trial

NEXT STORY
Cellectis to Present Preclinical Data on UCARTMESO Supporting Anti-Tumor Activity at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
PREV STORY
CRISPR Therapeutics Reports Positive Results from its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell malignancies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

DATA COLLECTION ON COVID-19 VACCINE EFFECTIVESS FOR CDC REQUIRED QUICK PIVOT

author_avatar
NASDAQ Market News

Sequana Medical announces 2019 Half Year Results and Year-to-date Business Update

author_avatar
NASDAQ Market News

Global Market for Biomarkers 2015-2020 – Cancer Markers, Cardiac Markers, Immunological Disease Markers, Infectious Disease Markers, Others

Dublin, May 16, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

author_avatar
NASDAQ Market News